These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31362405)

  • 1. Actinomycetes: The Antibiotics Producers.
    Mast Y; Stegmann E
    Antibiotics (Basel); 2019 Jul; 8(3):. PubMed ID: 31362405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actinomycetes, an Inexhaustible Source of Naturally Occurring Antibiotics.
    Takahashi Y; Nakashima T
    Antibiotics (Basel); 2018 May; 7(2):. PubMed ID: 29795019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Yōko, T., et al. Actinomycetes, an Inexhaustible Source of Naturally Occurring Antibiotics. Antibiotics 2018, 7, 45.
    Takahashi Y; Nakashima T
    Antibiotics (Basel); 2018 Aug; 7(3):. PubMed ID: 30110972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinomycetes as Producers of Biologically Active Terpenoids: Current Trends and Patents.
    Tarasova EV; Luchnikova NA; Grishko VV; Ivshina IB
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-Based Approach to New Antibiotic Producers Screening among Actinomycetes in the Course of the Citizen Science Project.
    Volynkina IA; Zakalyukina YV; Alferova VA; Belik AR; Yagoda DK; Nikandrova AA; Buyuklyan YA; Udalov AV; Golovin EV; Kryakvin MA; Lukianov DA; Biryukov MV; Sergiev PV; Dontsova OA; Osterman IA
    Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36139977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary metabolites and biodiversity of actinomycetes.
    Selim MSM; Abdelhamid SA; Mohamed SS
    J Genet Eng Biotechnol; 2021 May; 19(1):72. PubMed ID: 33982192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial agents from actinomycetes - a review.
    Mahajan GB; Balachandran L
    Front Biosci (Elite Ed); 2012 Jan; 4(1):240-53. PubMed ID: 22201868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel bioactive compounds from actinomycetes.
    Sanglier JJ; Wellington EM; Behal V; Fiedler HP; Ellouz Ghorbel R; Finance C; Hacene M; Kamoun A; Kelly C; Mercer DK
    Res Microbiol; 1993 Oct; 144(8):661-3. PubMed ID: 7908142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actinomycetes - The Repertoire of Diverse Bioactive Chemical Molecules: From Structures to Antibiotics.
    Baba IA; Wani ZA; Ali S; Ahmad Z; Mubarak MM
    Curr Top Med Chem; 2024 Mar; ():. PubMed ID: 38485679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mining Actinomycetes for Novel Antibiotics in the Omics Era: Are We Ready to Exploit This New Paradigm?
    Genilloud O
    Antibiotics (Basel); 2018 Sep; 7(4):. PubMed ID: 30257490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actinomycete-Derived Polyketides as a Source of Antibiotics and Lead Structures for the Development of New Antimicrobial Drugs.
    Robertsen HL; Musiol-Kroll EM
    Antibiotics (Basel); 2019 Sep; 8(4):. PubMed ID: 31547063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Scale Metabolic Reconstruction of Actinomycetes for Antibiotics Production.
    Mohite OS; Weber T; Kim HU; Lee SY
    Biotechnol J; 2019 Jan; 14(1):e1800377. PubMed ID: 30117679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare genera of actinomycetes as potential producers of new antibiotics.
    Lazzarini A; Cavaletti L; Toppo G; Marinelli F
    Antonie Van Leeuwenhoek; 2001 Sep; 79(3-4):399-405. PubMed ID: 11816986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare genera of actinomycetes as potential producers of new antibiotics.
    Lazzarini A; Cavaletti L; Toppo G; Marinelli F
    Antonie Van Leeuwenhoek; 2000 Dec; 78(3-4):399-405. PubMed ID: 11386363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new analog of dihydroxybenzoic acid from
    Janthanom R; Kikuchi Y; Kanto H; Hirose T; Tahara A; Ishii T; Thamchaipenet A; Inahashi Y
    Beilstein J Org Chem; 2024; 20():497-503. PubMed ID: 38440171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concepts and Methods to Access Novel Antibiotics from Actinomycetes.
    Hug JJ; Bader CD; Remškar M; Cirnski K; Müller R
    Antibiotics (Basel); 2018 May; 7(2):. PubMed ID: 29789481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possibility of the early identification of polyene antibiotic producers].
    Bibikova MV; Laĭko AV; Selezneva TI; Kovsharova IN
    Antibiotiki; 1975 Aug; 20(8):675-8. PubMed ID: 779625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Dimensions of Research on Actinomycetes: Quest for Next Generation Antibiotics.
    Jose PA; Jha B
    Front Microbiol; 2016; 7():1295. PubMed ID: 27594853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic screening strategy for rapid access to polyether ionophore producers and products in actinomycetes.
    Wang H; Liu N; Xi L; Rong X; Ruan J; Huang Y
    Appl Environ Microbiol; 2011 May; 77(10):3433-42. PubMed ID: 21421776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance-mediated isolation of scaffold-specific natural product producers.
    Thaker MN; Waglechner N; Wright GD
    Nat Protoc; 2014; 9(6):1469-79. PubMed ID: 24874813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.